title: Reduction of bacterial volatile sulfur compound production by licoricidin and licorisoflavan A from licorice.
abstract: Halitosis affects a large proportion of the population and is, in most cases, caused by the production of volatile sulfur compounds (VSCs), particularly methyl mercaptan and hydrogen sulfide, by specific bacterial species colonizing the oral cavity. In this study, a supercritical extract of Chinese licorice (Glycyrrhiza uralensis), and its major isoflavans, licoricidin and licorisoflavan A, were investigated for their effect on growth, VSC production and protease activity of Porphyromonas gingivalis, Prevotella intermedia and Solobacterium moorei, which have been associated with halitosis. The effects of licorice extract, licoricidin, and licorisoflavan A on VSC production in a saliva model were also tested. We first showed that licoricidin and licorisoflavan A, and to a lesser extent the licorice extract, were effective in inhibiting the growth of all three bacterial species, with minimal inhibitory concentrations in the range of 2-80 µg ml(-1). The licorice extract and the two isolates licoricidin and licorisoflavan A, were able to dose-dependently reduce VSC production by P. gingivalis, Prev. intermedia, and S. moorei as well as by a human saliva model. Although the extract and isolates did not inhibit the proteolytic activity of bacteria, they blocked the conversion of cysteine into hydrogen sulfide by Prev. intermedia. Lastly, the deodorizing effects of the licorice extract, licoricidin, and licorisoflavan A were demonstrated, as they can neutralize P. gingivalis-derived VSCs. Licorisoflavan A (10 µg ml(-1)) was found to be the most effective by reducing VSC levels by 50%. Within the limitations of this study, it can be concluded that a licorice supercritical extract and its major isoflavans (licoricidin and licorisoflavan A) represent natural ingredients with a potential for reducing bacterial VSC production and therefore for controlling halitosis.
authors.affiliation: Université Laval, Quebec City, QC, Canada.
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Tanabe
authors.forename: Jacynthe
authors.initials: J
authors.lastname: Desjardins
authors.forename: Chantal
authors.initials: C
authors.lastname: Bergeron
authors.forename: Stefan
authors.initials: S
authors.lastname: Gafner
authors.forename: Jacquelyn R
authors.initials: JR
authors.lastname: Villinski
authors.forename: Daniel
authors.initials: D
authors.lastname: Grenier
mesh_terms: D001578:Benzopyrans / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D006035:Glycyrrhiza / Q000737:chemistry; D006209:Halitosis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D009055:Mouth / Q000382:microbiology; D012463:Saliva / Q000382:microbiology*; D013457:Sulfur Compounds / Q000032:analysis*
chemical_list: D001578:Benzopyrans; D013457:Sulfur Compounds; C558581:licorisoflavan A; C401293:licoricidin